This question has been answered by the relevant Government Department.
Lord Hunt of Kings Heath to ask Her Majesty's Government what further proof of eligibility for treatment with liothyronine is required for those patients, in Clinical Commissioning Groups (CCG) who are members of the Pan Mersey Area Prescribing Committee, for whom an endocrinologist has confirmed levothyroxine treatment has not been suitable and has recommended they are prescribed liothyronine, and where the CCG is requiring an Individual Funding Request process be undergone before treatment can be permitted. HL457
Legend for business item text
† Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Member's Registered Interests
There are no interests to show.
Lord Hunt of Kings Heath